semaglutide novo nordisk Wegovy for the Treatment of Chronic Weight Management, US Novo Nordisk wins EU approval
Description
I no longer feel self-conscious about my neck, and I've regained my perfect jawline." - Victoria Anastasia, 42 years old Victoris, USA
$149$299/mo
Founders and investors see massive potential in the new drug class but funding is yet to flood startups in the sector.
Learn how GLP-1 weight loss programs may support heart health during American Heart Month
For a long time, it was considered a decent estimation for whether people were at a healthy weight
Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat
